Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy

Early Breast Cancer Trialist's Collaborative Group

The Lancet

January 1, 1992

10.1016/0140-6736(92)90997-h

Cited by 2,192

Abstract

Related Papers

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples

Richard Peto, M. C. Pike, P. Armitage et al.|British Journal of Cancer|1977|8.4k

MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis

Charles Warlow|The Lancet|1991|3.3k

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design

Richard Peto, Malcolm C. Pike, P. Armitage et al.|British Journal of Cancer|1976|2.3k

A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive Tumors

B. Fisher, Joseph Costantino, Carol Redmond et al.|New England Journal of Medicine|1989|1.5k

Menopause and Risk Factors for Coronary Heart Disease

Karen A. Matthews, Elaine N. Meilahn, Lewis H. Kuller et al.|New England Journal of Medicine|1989|1k